| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Arysta LifeScience plc (ARYS) | Morgan Stanley/ J.P. Morgan | $100.00 | n.a. | |||
| Dave & Buster’s Entertainment (PLAY) | Jefferies/ Piper Jaffray | $100.00 | n.a. | |||
| Energy & Exploration Partners (ENXP) | Citigroup/ Credit Suisse/ RBC Capital Markets | $400.00 | n.a. | |||
| Euronav NV (EURN ) | Deutsche Bank Securities | $100.00 | n.a. | |||
| Fifth Street Asset Management (FSAM) | Morgan Stanley/ J.P. Morgan/ Goldman Sachs/ RBC Capital Markets/ Credit Suisse/ SMBC Nikko | $200.00 | n.a. | |||
| Freshpet (TBA) | Goldman Sachs/ Credit Suisse | $100.00 | n.a. | |||
| Israel Corporation (ICL) | Morgan Stanley/ Barclays/ Deutsche Bank Securities/ Goldman Sachs/ BMO Capital Markets | 63.00 | $7.41 | $7.41 | $466.83 | n.a. |
| Kolltan Pharmaceuticals (KLTN) | Leerink Partners/ Stifel | $86.25 | n.a. | |||
| Mevion Medical Systems (MEV) | Jefferies/ Leerink Partners | $69.00 | n.a. | |||
| Performance Food Group (TBA) | Credit Suisse/ Barclays/ Wells Fargo Securities/ Morgan Stanley | $100.00 | n.a. | |||
| PRA Health Sciences (PRAH) | Jefferies/ Citigroup/ KKR/ UBS Investment Bank/ Credit Suisse/ Wells Fargo Securities | $375.00 | n.a. | |||
| Virobay (VBAY) | Piper Jaffray/ JMP Securities | $50.00 | n.a. | |||
| Xenon Pharmaceuticals (XENE) | Jefferies/ Wells Fargo Securities | $51.75 | n.a. | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| None | ||||||
| New Terms | ||||||
| AAC Holdings (AAC) | William Blair/ Raymond James | $75.00 | n.a. | |||
| Anchor BanCorp Wisconsin (ABCW) | Sandler ONeill & Partners/ Baird | $10.00 | n.a. | |||
| Atento S.A. (ATTO) | Morgan Stanley/ Credit Suisse/ Itaú BBA | 14.63 | $19.00 | $22.00 | $299.81 | n.a. |
| Capnia (CAPNU) | Maxim Group LLC | 1.85 | $6.00 | $6.00 | $11.10 | n.a. |
| Citizens Financial Group (CFG) | Morgan Stanley/ Goldman Sachs | 140.00 | $23.00 | $25.00 | $3,360.00 | n.a. |
| Cyber-Ark Software (CYBR) | J.P. Morgan/ Deutsche Bank Securities/ Barclays | 5.36 | $13.00 | $15.00 | $75.04 | n.a. |
| Eyegate Pharmaceuticals (EYEG) | Aegis Capital Corp | 1.92 | $12.00 | $14.00 | $25.00 | n.a. |
| Great Basin Scientific (GBSN)(u) | Dawson James Securities, Inc. | 2.50 | $6.00 | $7.00 | $16.25 | n.a. |
| Grupo Aval Acciones Y Valores S.A. (AVAL) | J.P. Morgan/ Goldman Sachs | 73.53 | $14.96 | $14.96 | $1,099.99 | n.a. |
| Harmony Merger (HRMNU) (u) | Cantor Fitzgerald & Co. | 10.00 | $10.00 | $10.00 | $100.00 | n.a. |
| ProQR Therapeutics B.V. (TBA) | Leerink Partners/ Deutsche Bank Securities | 6.25 | $11.00 | $13.00 | $75.00 | n.a. |
| Smart & Final Stores (SFS) | Credit Suisse/ Morgan Stanley/ Deutsche Bank Securities | 13.45 | $12.00 | $14.00 | $174.85 | n.a. |
| Travelport Worldwide LTD (TVPT) | Morgan Stanley/ UBS Securities/ Credit Suisse/ Deutsche Bank Securities | 30.00 | $14.00 | $16.00 | $450.00 | n.a. |
| Vitae Pharmaceuticals (VTAE) | Stifel/ BMO Capital Markets | 5.00 | $11.00 | $13.00 | $60.00 | n.a. |
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Sept. 8, 2014 | Manager(s) | Offered | Raised | Price | 9/15/14 | Change |
| ReWalk Robotics (RWLK) | Barclays/ Jefferies | 3.00 | $36.00 | $12.00 | $25.60 | 113.33% |
| Affimed Therapeutics B.V. (AFMD) | Jefferies/ Leerink Partners/ BMO Capital Markets | 8.00 | $56.00 | $7.00 | $5.76 | -17.71% |
